Small and medium-sized food and drink manufacturers are seeing signs of recovery after a difficult few years for the sector ...

The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...